Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Bicifadine is an inhibitor of the serotonin transporter (SERT), dopamine transporter (DAT), and norepinephrine transporter (NET).1 It binds these transporters (Kis = 2.4, 5.2, and 5.4 µM, respectively) and inhibits serotonin, dopamine, and norepinephrine reuptake in intact cells expressing the human transporters (IC50s = 117, 910, and 55 nM, respectively). Bicifadine increases the mechanical withdrawal threshold in a rat model of acute inflammatory pain induced by subplantar injection of brewer’s yeast (ED50 = 9.2 mg/kg) and decreases writhing in mouse model of persistent abdominal pain induced by phenyl-p-quinone (PPQ; ED50 = 13.2 mg/kg). It also reduces paw licking in the first and second phases of the formalin test in mice and rats when administered 30 minutes prior to formalin.
WARNING This product is not for human or veterinary use.
1. Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. J. Pharmacol. Exp. Ther. 321(3), 1208-1225 (2007).